+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sepsis Diagnostics - Global Markets by Assay & Cause with Executive and Consultant Guides and COVID-19 Related Sepsis Market Analysis and Forecasts 2020-2025

  • ID: 5206669
  • Report
  • January 2021
  • Region: Global
  • 356 Pages
  • Howe Sound Research
1 of 4
Rapid Results & COVID Pandemic Drive Race for a Predictive Sepsis Diagnostic

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter, Inc.
  • Cube Dx
  • GenMark Dx
  • Linear Diagnostics
  • Nanomix
  • MORE

Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies.

The publisher's facts and support = Your success.

The report forecasts the market size out to 2025. Growth is coming from the basic factors but the COVID Pandemic has changed the market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostic and the Genomics Revolution are merging to create new diagnostic opportunities.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter, Inc.
  • Cube Dx
  • GenMark Dx
  • Linear Diagnostics
  • Nanomix
  • MORE

Market Guides

  • Situation Analysis - COVID & Sepsis
  • Guide for Executives and Marketing Staff
  • Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition
1.1 An Overview of Sepsis Diagnostics
1.1.1 Sepsis the medical emergency
1.1.2 Sepsis Diagnosis and Comorbidity
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.3.4 Microbiology
1.3.5 Other Infectious Disease
1.3.6 Syndromic PoC
1.3.7 Biomarkers Molecular Diagnostics
1.3.8 Biomarkers Other
1.3.9 Limitations
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Sepsis - Current Science
2.1 What is Sepsis?
2.1.1 Organ Damage
2.1.2 Neonatal sepsis
2.1.3 Prognosis
2.2 Diagnosis
2.2.1 Infection Identification
2.2.2 Biomarkers
2.2.3 Differential diagnosis
2.2.4 The Cytokine Storm - Diagnostic Needs
2.3 Causes of Sepsis
2.3.1 Sepsis Progression
2.3.2 The Cytokine Storm - COVID and Other Situations
2.4 Prevalence
2.4.1 Impact of COVID on Sepsis Prevalence

3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Pharmaceutical/Reagent Supplier
3.1.4 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body

4. Market Trends
4.1 Factors Driving Growth
4.1.1 Increasing Prevalence
4.1.2 Antimicrobial Resistance
4.1.3 Increasing Diagnosis
4.1.4 Multiplex Diagnostics Impacts
4.1.5 The Aging World
4.1.6 COVID Market Impact
4.2 Factors Limiting Growth
4.2.1 The Cost Curve Shrinks the Market
4.2.2 The Diagnostics Dillemma
4.2.3 Adoption Lag and Cost Control
4.3 Diagnostic Technology Development
4.3.1 The Multiplex Opportunity
4.3.2 Shifting Role of Physicians in Diagnosis
4.3.3 Diagnostics Moves Out of the Lab
4.3.4 Biomarkers and Algorithms
4.3.5 Rapid Testing Changing Medical Practice
4.3.6 Genome Role and Big Data
4.3.6 The Next Five Years

5. Sepsis Diagnostics - Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section

  • SpeeDx Developing Respiratory Virus Host-Response Test
  • Scanogen Developing Blood Infection Test with Sepsis Application
  • Inflammatix Moving Into COVID Test Market and Developing New Sepsis Dx
  • Immunexpress, Biocartis to Roll Out Sepsis Test
  • Sepset Biosciences Using COVID-19 Patient Samples to Validate Sepsis Test
  • Immunexpress to Develop Sepsis Test for Coronavirus Patient Triage
  • DNAe Developing POC Sequencing Platform for Coronavirus, Sepsis
  • NGS technique offers quick, accurate diagnosis of sepsis
  • Portable device diagnoses sepsis faster
  • Ontera and QuantuMDx Collaborate to Advance Sepsis Diagnosis
  • Blood Test Accurately Predicts Sepsis Severity
  • Sepsis diagnostics: HHS to advance development of Cytovale rapid test
  • Mologic Developing Sepsis Test Using Multimarker
  • Abionic: Study Demonstrates Diagnosis of Sepsis in 5 Minutes
  • T2 Biosystems Introduces New Data and Updates for Rapid Diagnostic Technology
  • Sepsis found to fit into 4 subtypes
  • GenMark Diagnostics Receives FDA Clearance for Blood Panel
  • Novacyt, Immunexpress Extend Sepsis Assay Development Partnership
  • New Test Could Diagnose Sepsis Faster
  • Immunexpress Wins $745K HHS Contract for Rapid Sepsis Assay
  • Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals
  • Luminex to Pay $75M for MilliporeSigma's Flow Cytometry Research Portfolio
  • Experimental 2.5-minute Sepsis Test Discovered
  • sphingotec raises €20 million
  • SeLux Diagnostics Announces Sepsi U.S. HHS/BARDA Research Funding
  • Roche PCT assay cleared as tool in fight against Sepsis
  • GeneFluidics selected as finalist for AMR Challenge
  • BioDirection, Inc. Announces System to Diagnose and Monitor Sepsis
  • sphingotec Adding Advanced POC Testing Platform
  • Rapid Detection Using DNAe’s LiDia® Bloodstream Infection Technology
  • Septec Team Working on 15 Minute Sepsis Diagnosis
  • Abionic Announces Rapid Sepsis PoC Diagnostic

6. Profiles of Key Companies

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

7. Sepsis Diagnostic Markets
7.1 Sepsis Diagnostics - Global Market Overview by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country

8. Global Sepsis Diagnostics Markets - By Assay Type
8.1 Global Market by Diagnostic Type - Overview
8.1.1 Table - Global Market by Diagnostic Type
8.1.2 Chart - Global Market by Assay Type
8.1.3 Chart - Global Market by Type - Base Year
8.1.4 Chart - Global Market by Type - Final Year
8.1.4 Chart - Global Market by Type - Share by Year
8.2 Sepsis Diagnostic - Microbiology
8.2.1 Table Sepsis Diagnostic Microbiology - by Country
8.2.2 Chart - Sepsis Diagnostic Microbiology Growth
8.3 Sepsis Diagnostic - Syndromic PoC Panel
8.3.1 Table Sepsis Diagnostic Syndromic PoC Panel - by Country
8.3.2 Chart - Sepsis Diagnostic Syndromic PoC Panel Growth
8.4 Sepsis Diagnostic - Other Infectious Disease
8.4.1 Table Sepsis Diagnostic Other ID - by Country
8.4.2 Chart - Sepsis Diagnostic - Other Infectious Disease Growth
8.5 Sepsis Diagnostic - Biomarker Molecular Diagnostic
8.5.1 Table Sepsis Diagnostic Biomarker MDx - by Country
8.5.2 Chart - Sepsis Diagnostic - Biomarker MDx Growth
8.6 Sepsis Diagnostic - Biomarker Other
8.6.1 Table Sepsis Diagnostic Biomarker Other - by Country
8.6.2 Chart - Sepsis Diagnostic - Biomarker Other Growth

9. Global Sepsis Diagnostics Markets - By Cause
9.1 Global Market by Cause - Overview
9.1.1 Table - Global Market by Cause
9.1.2 Chart - Global Market by Cause
9.1.3 Chart - Global Market by Type - Base Year
9.1.4 Chart - Global Market by Type - Final Year
9.1.4 Chart - Global Market by Cause - Share by Year
9.2 Sepsis Diagnostic - GastroIntestinal
9.2.1 Table Sepsis Diagnostic GastroIntestinal - by Country
9.2.2 Chart - Sepsis Diagnostic GastroIntestinal Growth
9.3 Sepsis Diagnostic - Respiratory COVID-19
9.3.1 Table Sepsis Diagnostic Respiratory COVID-19- by Country
9.3.2 Chart - Sepsis Diagnostic Respiratory COVID-19
9.4 Sepsis Diagnostic - Respiratory Other
9.4.1 Table Sepsis Diagnostic Respiratory Other - by Country
9.4.2 Chart - Sepsis Diagnostic - Respiratory Other Growth
9.5 Sepsis Diagnostic - Newborn
9.5.1 Table Sepsis Diagnostic Newborn - by Country
9.5.2 Chart - Sepsis Diagnostic - Newborn Growth
9.6 Sepsis Diagnostic - Other Cause
9.6.1 Table Sepsis Diagnostic Other Cause - by Country
9.6.2 Chart - Sepsis Diagnostic - Other Cause Growth

Appendices

  • United States Medicare System: 2020 Clinical Laboratory Fees Schedule

List of Tables
Table 1 Lab Spending 2014 to 2024
Table 2 sepsis biomarkers - Established and potential
Table 3 Market Players by Type
Table 4 Five Factors Driving Growth
Table 5 Three Factors Limiting Growth
Table 6 Global Sepsis Diagnostics Market by Country/Region
Table 7 Global Market by Assay Type
Table 8 Sepsis Diagnostic Microbiology by Country
Table 9 Sepsis Diagnostic Syndromic PoC Panel by Country
Table 10 Sepsis Diagnostic Other ID by Country
Table 11 Sepsis Diagnostic Biomarker MDx by Country
Table 12 Sepsis Diagnostic Biomarker Other by Country
Table 13 Global Market by Cause
Table 14 Sepsis Diagnostic GastroIntestinal by Country
Table 15 Sepsis Diagnostic Respiratory COVID-19 by Country
Table 16 Sepsis Diagnostic Respiratory Other by Country
Table 17 Sepsis Diagnostic Newborn by Country
Table 18 Sepsis Diagnostic Other Cause by Country
Table 19 2020 Clinical Lab Fee Schedule

List of Figures
Figure 1 Sepsis Survival graph
Figure 2 Percentage of Sepsis Patients with Comorbidity
Figure 3 Clinical Lab Spending 2014 to 2024
Figure 4 Sepsis Clinical Progression
Figure 5 Deaths From Drug Resistant Infections 2050
Figure 6 Aggregate Age of World Population
Figure 7 Growth in Health Care Spending Developing World
Figure 8 Comparing The New Diagnostics and Traditional Testing
Figure 9 Growth rates of Sepsis Diagnostics
Figure 10 Global Market Share Chart
Figure 11 Sepsis Diagnostics Market Segment Shift Base vs Final year
Figure 12 Sepsis Diagnostics Market by Type Base Year
Figure 13 Sepsis Diagnostics Market by Type Final Year
Figure 14 Type Share by Year
Figure 15 Sepsis Diagnostic Microbiology Growth
Figure 16 SEPSIS DIAGNOSTICS Syndromic POC Panel Growth
Figure 17 Sepsis Diagnostic Other Infectious Disease Growth
Figure 18 Sepsis Diagnostic Molecular Diagnostics Growth
Figure 19 Sepsis Diagnostic Biomarker Other Growth
Figure 20 Sepsis Diagnostics Market Cause Segment Shift Base vs Final year
Figure 21 Sepsis Diagnostics by Cause Segment Base Year
Figure 22 Sepsis Diagnostics Market by Cause Segment Final Year
Figure 23 Cause Share by Year
Figure 24 Sepsis Diagnostic GastroIntestinal Growth
Figure 25 SEPSIS DIAGNOSTICS Respiratory COVID-19
Figure 26 Sepsis Diagnostic Respiratory Other Growth
Figure 27 Sepsis Diagnostic Newborn Growth
Figure 28 Sepsis Diagnostic Other Cause Growth

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis
  • bioMérieux Diagnostics
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc
Note: Product cover images may vary from those shown
Adroll
adroll